Antidepressant Mechanisms and Dosages of Aripiprazole, Amisulprid, and Cariprazin

Introduction to Antidepressant Mechanisms

Aripiprazole, Amisulprid, and Cariprazin work antidepressively through dopaminergic mechanisms, with Cariprazin showing the strongest D3 receptor preference and Amisulprid selectively blocking presynaptic D2/D3 autoreceptors at low doses (50 mg twice daily) 1

The American Psychiatric Association recommends Aripiprazole as a partial D2/D3 agonist, which stabilizes the dopaminergic system 2
Aripiprazole improves negative symptoms significantly (standardized mean difference −0,41, 95% CI −0,79 to −0,03, p = 0,036) 1, 2
The recommended dosage for Aripiprazole's antidepressive effect is 5-15 mg/day, with dose reduction in poor CYP2D6 metabolizers 3, 2
Amisulprid blocks presynaptic D2/D3 autoreceptors selectively at low doses (50-100 mg/day), increasing dopamine release 1
Amisulprid is particularly effective for negative symptoms without pronounced positive symptomatology 1
The recommended dosage for Amisulprid's antidepressive/negative symptom effect is 50 mg twice daily 1
Cariprazin's dosage is typically 1.5-6 mg/day, with lower doses sufficient for negative symptoms 1

Olanzapin works antidepressively through multiple receptor interactions, particularly 5-HT2A antagonism and noradrenergic modulation, but is not a first-line therapy for depression due to severe metabolic side effects 4
The FDA approves Olanzapin in combination with Fluoxetine for bipolar depression 4
Olanzapin's multireceptor antagonism, including strong blockade of 5-HT2A, H1, and muscarinic receptors, contributes to mood stabilization 3
Metformin augmentation is recommended when using Olanzapin or Clozapin to mitigate metabolic side effects 1

For metabolic syndrome or metabolic risk factors, Aripiprazole 5-15 mg/day is recommended as first-line therapy 1
For primary negative symptoms with controlled positive symptoms, Cariprazin or Aripiprazole are recommended as first-line options 1
For bipolar depression, Olanzapin is recommended only in combination with Fluoxetine, with Metformin augmentation 4, 1